
REPL

Replimune Group Inc (REPL) Latest News & Updates
Explore latest REPL News and Updates
Stay updated on REPL with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in REPL
Order type
Buy in
Order amount
Est. shares
0 shares

GlobeNewsWire •





Zacks Investment Research •

Proactive Investors •

GlobeNewsWire •


Zacks Investment Research •

GlobeNewsWire •

Zacks Investment Research •

GlobeNewsWire •

Seeking Alpha •

Zacks Investment Research •




GlobeNewsWire •

The Motley Fool •

Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
GlobeNewsWire •

GlobeNewsWire •


Zacks Investment Research •

Explore latest REPL News and Updates
Stay updated on REPL with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in REPL
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.